caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1649272576

Edward RheeMD

NephrologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Edward Rhee's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 55 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Sandra Barrow
Nephrology · Santa Rosa, CA
75632
NPI 125533553566152
Abdul Khan
Nephrology · Houston, TX
62337
Chun Lin
Interventional Cardiology · San Francisco, CA
57308
BRENNAN, THOMAS49161
John Haddad
Diagnostic Radiology · Houston, TX
40148
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
40102
HEDRICK, THOMAS40167
David Katz
Diagnostic Radiology · Houston, TX
39146
Kapil Shroff
Diagnostic Radiology · Houston, TX
39102
Su Chang
Cardiology · Houston, TX
39172
Rajesh Amin
Diagnostic Radiology · Houston, TX
35178
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
859
Unique beneficiaries
—
Total services
8,617
Distinct HCPCS
19
Medicare payment
$305K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 883 Nephrology providers in TX — top quintile (cohort median 1,432).
PRESCRIBING · PART D · 2024
Total Rx claims
30
Beneficiaries
—
Total drug cost
$8K
Distinct drugs
2
Brand share
56.7%
Top prescribed drugs
Dapagliflozin Propanediol17 claims
Furosemide13 claims
QUALITY · MIPS · 2024
Final MIPS score
98.9
Quality
82.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
97.0
Payment adjustment
1.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$50
Payment records
2
By payment type
Food and Beverage$50